mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

mTOR Pathway As a Potential Target In a Subset of Human Medulloblastoma

Published:2014-04-16 Issue:4 Volume:20 Page:893-900
ISSN:1219-4956
Container-title:Pathology & Oncology Research
language:en
Short-container-title:Pathol. Oncol. Res.

Author:

Pócza Tímea,Sebestyén Anna,Turányi Eszter,Krenács Tibor,Márk Ágnes,Sticz Tamás Béla,Jakab Zsuzsanna,Hauser Péter

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12253-014-9771-0.pdf

Reference39 articles.

1. Hatten ME, Roussel MF (2011) Development and Cancer of the Cerebellum. Trends Neurosci 34:134–142

2. Roussel MF, Hatten ME (2011) Cerebellum Development and Medulloblastoma. Curr Top Dev Biol 94:235–282

3. Crawford JR, MacDonald TJ, Packer RJ (2007) Medulloblastoma in Childhood: new Biological Advances. Lancet Neurol 6:1073–1085

4. Massimino M, Giangaspero F, Garrè ML, Gandola L, Poggi G, Biassoni V, Gatta G, Rutkowski S (2011) Childhood Medulloblastoma. Crit Rev Oncol Hematol 79:65–83

5. Gottardo NG, Gajjar A (2008) Chemotherapy for Malignant Brain Tumors of Childhood. J Child Neurol 23:1149–1159

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PUMC-MB1 is a novel group 3 medulloblastoma preclinical model, sensitive to PI3K/mTOR dual inhibitor;Journal of Neuro-Oncology;2024-04-25

2. mTOR hyperactivity and RICTOR amplification as targets for personalized treatments in malignancies;Pathology and Oncology Research;2024-03-07

3. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario;Pharmaceutics;2023-02-16

4. Immunosuppression in Medulloblastoma: Insights into Cancer Immunity and Immunotherapy;Current Treatment Options in Oncology;2021-07-30

5. Inositol treatment inhibits medulloblastoma through suppression of epigenetic-driven metabolic adaptation;Nature Communications;2021-04-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3